Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W; MARPLE Study Group. Schrader J, et al. Among authors: zidek w. J Hypertens. 2006 Mar;24(3):541-8. doi: 10.1097/01.hjh.0000209991.48928.c4. J Hypertens. 2006. PMID: 16467658 Clinical Trial.
Low-grade albuminuria and cardiovascular risk : what is the evidence?
Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P, Pittrow D, Böhm M. Schmieder RE, et al. Among authors: zidek w. Clin Res Cardiol. 2007 May;96(5):247-57. doi: 10.1007/s00392-007-0510-3. Epub 2007 Apr 26. Clin Res Cardiol. 2007. PMID: 17453140 Review.
The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P; PHARAO Study Group. Lüders S, et al. Among authors: zidek w. J Hypertens. 2008 Jul;26(7):1487-96. doi: 10.1097/HJH.0b013e3282ff8864. J Hypertens. 2008. PMID: 18551027 Clinical Trial.
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group. Schrader J, et al. Among authors: zidek w. Stroke. 2005 Jun;36(6):1218-26. doi: 10.1161/01.STR.0000166048.35740.a9. Epub 2005 May 5. Stroke. 2005. PMID: 15879332 Clinical Trial.
[Antihypertensive treatment after stroke: target blood pressure and treatment recommendations].
Schlaganfall-Kommission der Deutschen Hypertonie-Gesellschaft; Schrader J, Lüders S, Haller H, Kolloch R, Schulz EG, Trenkwalder P, Zidek W. Schlaganfall-Kommission der Deutschen Hypertonie-Gesellschaft, et al. Among authors: zidek w. Dtsch Med Wochenschr. 2012 Nov;137(48):2511-4. doi: 10.1055/s-0032-1327230. Epub 2012 Nov 20. Dtsch Med Wochenschr. 2012. PMID: 23168987 Review. German. No abstract available.
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.
Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhäupl K, Diener HC, Dominiak P; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. Schrader J, et al. Among authors: zidek w. Stroke. 2003 Jul;34(7):1699-703. doi: 10.1161/01.STR.0000075777.18006.89. Epub 2003 Jun 19. Stroke. 2003. PMID: 12817109 Clinical Trial.
570 results